Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS West Yorkshire Integrated Care Board
White Rose House, West Parade
Wakefield
WF1 1LT
UK
Contact person: Ben Pursey
E-mail: wyicb-kirk.procurement@nhs.net
NUTS: UKE4
Internet address(es)
Main address: https://www.westyorkshire.icb.nhs.uk/
Address of the buyer profile: https://www.westyorkshire.icb.nhs.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHSWYICB - Neurodevelopmental Assessment Service
Reference number: C354190
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
Neurodevelopmental Assessment (ASD and/or ADHD) and ADHD medication for Children, Young People and Adults in West Yorkshire
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKE4
II.2.4) Description of the procurement
NHS West Yorkshire Integrated Care Board (NHS WY ICB) is committed to implementing the local service framework for mental health, learning disability and ASD. Its ambition is to develop a “local service framework” so there is “…more consistency in how our providers deliver their services throughout the assessment, diagnosis, and post-diagnosis support processes.” <br/><br/>Under the NHS Patient Choice Framework there is a duty on NHS WY ICB to support choice of provider options for people accessing mental health services, in the same way choice is supported for other planned care services . This includes services related to ASD and ADHD assessment, diagnosis, and where applicable, treatment. <br/><br/>There is a duty on NHS WY ICB to support choice of provider options for people accessing mental health services, in the same way we support choice for other planned care services . NHS WY ICB also has a duty to ensure services are safe, high quality, cost effective and efficient.<br/>• Support choice for children, young people and adults (all-age).<br/>• Improve outcomes for children, young people and adults (all-age).<br/>• Children, young people and adults (all-age) are referred to services and providers where care is safe, high-quality, clinically appropriate and cost effective.<br/>• Services and providers have been through the relevant due diligence and assurance mechanisms.<br/>• Minimise waiting times for an assessment and/or ADHD treatment (where applicable).<br/><br/>Providers are required to deliver and outcomes they are required to achieve if they provide either for Children and Young People, Adults or both any of the following services:<br/>1. Diagnostic assessments for ASD<br/>2. Diagnostic assessments for ADHD and medication as a form of treatment for ADHD in line with West Yorkshire Area Prescribing Committee Amber (shared care) guidelines. <br/><br/>The providers will be accredited for:<br/>Lot 1 - ASD Assessment 0-5<br/>Lot 2 - ASD Assessment 6-17<br/>Lot 3 - ASD Assessment 18+<br/>Lot 4 - ADHD Assessment & Treatment 6-17<br/>Lot 5 - ADHD Assessment & Treatment 18+<br/>Lot 6 - ASD/ADHD Assessment Combined and ADHD Treatment 6-17<br/>Lot 7 - ASD/ADHD Assessment Combined and ADHD Treatment 18+<br/><br/>For Lots 4-7, providers will be expected to either:<br/>a) be able to prescribe/ intend to develop a prescribing offer OR <br/>b) have written agreements in place in place with prescriber/sub-contract prescribing <br/>by the long stop date of 6 months from contract commencement.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/07/2025
End:
30/06/2027
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
30/04/2025
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until:
01/04/2026
IV.2.7) Conditions for opening of tenders
Date:
30/04/2025
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
WYICB PSR Review Panel
White Rose House, West Parade
Wakefield
WF1 1LT
UK
VI.4.2) Body responsible for mediation procedures
NHS England Independent Patient Choice and Procurement Panel
London
London
SE1 8UG
UK
Internet address(es)
URL: https://www.england.nhs.uk/commissioning/how-commissioning-is-changing/nhs-provider-selection-regime/independent-patient-choice-and-procurement-panel/
VI.5) Date of dispatch of this notice
15/04/2025